From its humble beginnings, IBSA is a large multinational pharmaceutical company present in more than 90 countries across five continents, with 17 subsidiaries. It has more than 2,000 collaborators, 90 patent families and products covering 10 therapeutic areas including cosmetic dermatology with Profhilo®, Aliaxin® and Viscoderm®.
Founded in 1945, IBSA started life as a small pharmaceutical company in Lugano, Switzerland. By 1985, it was acquired by the current CEO and Group President Arturo Licenziati.
His vision saw IBSA’s revival and growth into the 1990s, thanks to the production of a treatment for osteoarthritis which saw turnover increase and paved the way for a new manufacturing plant.
With a desire to expand into other markets, Arturo entered a partnership with Laboratoires Genevrier in 1988, now the French subsidiary, IBSA Pharma SAS, followed by the establishment of IBSA…
